USAGAINSTALZHEIMER'S ACTIONPub 78
Pub 78
Programs
USAgainstAlzheimer's Action Initiatives
SINCE OUR FOUNDING IN 2010, USAGAINSTALZHEIMER'S ACTION HAS WORKED WITH PEOPLE AND ORGANIZATIONS ACROSS SECTORS TO ACHIEVE MILESTONES, INCLUDING:- SECURING THE NATIONAL GOAL OF PREVENTING AND EFFECTIVELY TREATING ALZHEIMER'S BY 2025 THROUGH THE NATIONAL ALZHEIMER'S PROJECT ACT.- INCREASING FEDERAL INVESTMENT IN ALZHEIMER'S RESEARCH. USAGAINSTALZHEIMER'S ACTION PLAYED A KEY ROLE IN THE $289 MILLION INCREASE IN THE 2022 BUDGET FOR RESEARCH THROUGH THE NATIONAL INSTITUTES OF HEALTH (NIH). AS A RESPECTED ADVOCATE, USAGAINSTALZHEIMER'S ACTION HAS HELPED DRIVE NIH FUNDING INCREASES FROM YEARLY AVERAGES OF $400 MILLION A DECADE EARLIER TO NEARLY $3.5 BILLION IN FY2022. (CONTINUED ON SCHEDULE O)- PROMOTING PASSAGE OF THE CHANGE (CONCENTRATING ON HIGH-VALUE ALZHEIMER'S NEEDS TO GET TO AN END) ACT IN CONGRESS, STRESSING THE HUGE IMPACT THE CHANGE ACT WOULD HAVE IN ENCOURAGING EARLY ASSESSMENT AND DIAGNOSIS OF ALZHEIMER'S DISEASE AND RELATED DEMENTIAS. - WORKING AGGRESSIVELY THROUGH ADVERTISING AND GRASSROOTS CAMPAIGNS TO ENSURE MEDICARE COVERAGE FOR ALZHEIMER'S TREATMENTS APPROVED BY THE FOOD AND DRUG ADMINISTRATION (FDA) AS WELL AS NECESSARY DIAGNOSTICS TESTS.GeographiesNot indicatedDatesJan 1, 2022 – Dec 31, 2022Source990No causes providedNo populations provided–$2.9M
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)